Specific contribution of methionine and choline in nutritional nonalcoholic steatohepatitis: impact on mitochondrial S-adenosyl-L-methionine and glutathione.
about
Gut Microbiota and Lifestyle Interventions in NAFLDMitochondrial dysfunction and tissue injury by alcohol, high fat, nonalcoholic substances and pathological conditions through post-translational protein modificationsNonalcoholic fatty liver disease: update on pathogenesis, diagnosis, treatment and the role of S-adenosylmethionineLow-carbohydrate ketogenic diets, glucose homeostasis, and nonalcoholic fatty liver diseaseTh17 involvement in nonalcoholic fatty liver disease progression to non-alcoholic steatohepatitisSphingolipids and phospholipids in insulin resistance and related metabolic disorders.Role of adipose tissue in methionine-choline-deficient model of non-alcoholic steatohepatitis (NASH)Modeling progressive non-alcoholic fatty liver disease in the laboratory mouse.Role of white adipose lipolysis in the development of NASH induced by methionine- and choline-deficient diet.S-adenosylmethionine in liver health, injury, and cancer.Role of Mitochondria in Alcoholic Liver DiseaseThe follicular microenviroment as a predictor of pregnancy: MALDI-TOF MS lipid profile in cumulus cells.Higher dietary choline intake is associated with lower risk of nonalcoholic fatty liver in normal-weight Chinese women.Activation of the Nrf2-ARE pathway in hepatocytes protects against steatosis in nutritionally induced non-alcoholic steatohepatitis in miceRole of choline deficiency in the Fatty liver phenotype of mice fed a low protein, very low carbohydrate ketogenic diet.Histone modifications and alcohol-induced liver disease: are altered nutrients the missing link?Oxidative stress promotes pathologic polyploidization in nonalcoholic fatty liver disease.Sphingolipid metabolism, oxidant signaling, and contractile function of skeletal muscleRedox biology of the intestineIntestinal redox biology and oxidative stressEvaluation of Methionine Content in a High-Fat and Choline-Deficient Diet on Body Weight Gain and the Development of Non-Alcoholic Steatohepatitis in Mice.Altered arsenic disposition in experimental nonalcoholic fatty liver disease.Mitochondrial GSH determines the toxic or therapeutic potential of superoxide scavenging in steatohepatitis.Choline and methionine differentially alter methyl carbon metabolism in bovine neonatal hepatocytes.Hedgehog controls hepatic stellate cell fate by regulating metabolismCholine metabolism provides novel insights into nonalcoholic fatty liver disease and its progression.Statins Increase Mitochondrial and Peroxisomal Fatty Acid Oxidation in the Liver and Prevent Non-Alcoholic Steatohepatitis in Mice.Genetic predisposition in NAFLD and NASH: impact on severity of liver disease and response to treatment.Sex-specific metabolic interactions between liver and adipose tissue in MCD diet-induced non-alcoholic fatty liver disease.Molecular alterations in hepatocarcinogenesis induced by dietary methyl deficiency.Creatine supplementation as a possible new therapeutic approach for fatty liver disease: early findings.Compounds of the sphingomyelin-ceramide-glycosphingolipid pathways as secondary messenger molecules: new targets for novel therapies for fatty liver disease and insulin resistance.An improved mouse model that rapidly develops fibrosis in non-alcoholic steatohepatitis.Pivotal role of liver sinusoidal endothelial cells in NAFLD/NASH progression.Metabolomic characteristics of cholesterol-induced non-obese nonalcoholic fatty liver disease in mice.Comparative study of fatty liver induced by methionine and choline-deficiency in C57BL/6N mice originating from three different sources.Kupffer cells ameliorate hepatic insulin resistance induced by high-fat diet rich in monounsaturated fatty acids: the evidence for the involvement of alternatively activated macrophagesS-adenosyl methionine prevents endothelial dysfunction by inducing heme oxygenase-1 in vascular endothelial cells.Serological and Histological Examination of a Nonalcoholic Steatohepatitis Mouse Model Created via the Administration of Monosodium Glutamate.ASMase regulates autophagy and lysosomal membrane permeabilization and its inhibition prevents early stage non-alcoholic steatohepatitis.
P2860
Q26749783-E646F28B-DA31-4CB7-9E0F-0FCDFD24665DQ26824709-592D65F7-AC9B-497D-A7C3-5FFF4FA74044Q26992163-374C5795-7B45-4542-A96A-DC1485EFDF80Q27007233-1F749E2E-9F63-4452-BBC8-DBE67CC02D08Q28067738-18AB8CFA-8954-4C45-892B-436D61419F84Q30241943-4A8C28B4-20F2-43AF-9E6E-81612334A485Q33665070-4909DC18-3761-434D-96B0-7AB8EF5E5E91Q34185231-8185667A-3660-44E9-A621-E89AEBE06400Q34302360-843E52CF-CD95-46D2-94F5-3D9DA5401CDAQ34306534-18C66448-A939-4BE9-843F-4173E6D12E84Q34377243-AC7D7584-D5F5-41D9-8337-FF2313799002Q34411666-C27833AB-2E71-411C-A173-73090F765B7AQ34502294-90D65FAC-E2A1-4F6A-91E7-7508D8AFDA14Q34605967-0E3101C2-0B9F-4908-80EE-E79CE7037A22Q34979884-01E428B4-92D6-413F-8283-04CFBFC4DF42Q35012707-B6761A52-DBF4-49B3-A670-E09FC88B30E4Q35183888-0C3B2B2D-A376-409D-BF0A-AD88F12E294CQ35222194-C0A267CB-4EF8-4B3B-840A-8D9B53324733Q35534376-167BF21D-B8B9-446F-A31F-A578E03E6BE0Q36095043-F8416584-8F20-4F96-9BB1-C9FB887C3942Q36159376-A71119EC-917B-4500-AF23-54482EB3AE1AQ36174255-8BDF2655-05DA-4B5C-8150-50B36FB6EB2FQ36243645-3DEBE242-BDDF-472D-BABA-1C0F21036F0FQ36267782-77E91D42-06A2-4EB1-854F-3296F8828FDDQ36345406-A2AA4482-A8D9-4436-A6D6-98A49DDB19F8Q36695961-816041CA-E9E8-4AB4-AE34-F64B55A3B50AQ37348597-84C64917-3ACA-4172-9AB0-EC28B0745409Q37362755-9FC68033-929F-41E5-97C4-DE889401D2C5Q37565005-0EA4ECEE-5BB0-4BBE-B232-68894A5C020DQ37957798-4DFC9A99-4EF0-462E-8152-A2BE7E85866BQ38718576-DC8496CB-201D-450E-8609-A7E599FE77DDQ38833111-CF43B312-B488-4475-A38A-E2D85E216D50Q39257691-21B859A4-566D-4271-9F10-AB2C0E1CB300Q40691956-76F132A7-A37A-4371-87A6-8C5102DA839EQ41094296-EE127817-9782-4619-8C1F-06DA145D7BDFQ41125952-C2CE735E-8779-487D-AFEA-7C933C9D5A95Q41764241-AF08AA1F-6213-4921-A182-10D48583AA05Q41864805-1695476E-D0BF-4E76-ADB8-FE554C9EF079Q41905919-03AAEBA4-9EED-43C5-B128-B4764531B9AAQ41921041-D3212CA7-F14B-4E16-B958-66FF818B1624
P2860
Specific contribution of methionine and choline in nutritional nonalcoholic steatohepatitis: impact on mitochondrial S-adenosyl-L-methionine and glutathione.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Specific contribution of methi ...... -L-methionine and glutathione.
@ast
Specific contribution of methi ...... -L-methionine and glutathione.
@en
type
label
Specific contribution of methi ...... -L-methionine and glutathione.
@ast
Specific contribution of methi ...... -L-methionine and glutathione.
@en
prefLabel
Specific contribution of methi ...... -L-methionine and glutathione.
@ast
Specific contribution of methi ...... -L-methionine and glutathione.
@en
P2093
P2860
P50
P356
P1476
Specific contribution of methi ...... l-L-methionine and glutathione
@en
P2093
Carmen García-Ruiz
Francisco Caballero
Joan Caballeria
Montserrat Elena
Nuria Matías
Raquel Fucho
P2860
P304
18528-18536
P356
10.1074/JBC.M109.099333
P407
P577
2010-04-15T00:00:00Z